No lot number information was supplied; therefore, no review of the manufacturing paperwork could be performed.Concomitant medications were aspirin (acetylsalicylic acid), amlodipine, simvastatin, hydralazine, clonidine, carvedilol, renvela (sevelamer carbonate), sensipar (cinacalcet hydrochloride), and nephro-vite (ascorbic acid, biotin, calcium pantothenate, cyanocobalamin, folic acid, nicotinamide, pyridoxine hydrochloride, riboflavin, thiamine hydrochloride).
|
It was reported to gore that on (b)(6) 2016, a study patient was implanted with a gore propaten vascular graft in the right upper arm as a conduit.The patient was believed to be on plavix (clopidogrel) and therefore was not started on aspirin as part of the discharge orders.On (b)(6) 2016, the patient was not taking aspirin and patient denied taking plavix.The patient was started on aspirin 81 mg on (b)(6) 2016.On (b)(6) 2016, the patient's graft was found to be occluded.The patient had a procedure of a fistulogram, mechanical thrombectomy and installation of tissue plasminogen activator (tpa) and heparin for a thrombosis of his vascular study conduit.A balloon angioplasty using an 8mm x 6cm balloon was performed to macerate the thrombus within the conduit.Heparin and tpa was instilled and a venography revealed normal outflow and a good thrill was restored.The occlusion was resolved successfully on (b)(6) 2016.On (b)(6) 2016, the study patient experienced thrombosis in the implanted gore propaten vascular graft.On the same date, the patient underwent resection of the arteriovenous (av) graft, placement of a new 6mm gore propaten vascular graft, and the event was resolved.
|